Natera, Inc S-3ASR, filed Nov 12, 2026
Natera, Inc. (NTRA)
Natera registered 68,023 shares for potential resale by unnamed, non-affiliated selling stockholders. The total includes 45,533 closing shares issued on or about November 10, 2026 and an estimated 22,490 additional shares; Natera receives no proceeds. AI summary
SECURITIES AND EXCHANGE COMMISSION
UNDER
THE SECURITIES ACT OF 1933
| |
Delaware
|
| |
01-0894487
|
|
| |
(State or other jurisdiction of
incorporation or organization) |
| |
(I.R.S. Employer
Identification Number) |
|
Building A Suite 100
Austin, Texas 78753
(650) 980-9190
Chief Financial Officer
Natera, Inc.
13011 McCallen Pass
Building A Suite 100
Austin, Texas 78753
(650) 980-9190
| |
Branden C. Berns
|
| |
Daniel Rabinowitz, Esq.
|
|
| |
Gibson, Dunn & Crutcher LLP
|
| |
Secretary and Chief Legal Officer
|
|
| |
One Embarcadero Center, Suite 2600
|
| |
Natera, Inc.
|
|
| |
San Francisco, CA 94111
|
| |
13011 McCallen Pass
|
|
| |
(415) 393-8200
|
| |
Building A Suite 100
|
|
| | | | |
Austin, Texas 78753
|
|
| | | | |
(650) 980-9190
|
|
| | Large accelerated filer | | | ☒ | | | Accelerated filer | | | ☐ | |
| | Non-accelerated filer | | | ☐ | | | Smaller reporting company | | | ☐ | |
| | | | | | | | Emerging growth company | | | ☐ | |
| | | |
Page
|
| |||
| | | | | 1 | | | |
| | | | | 3 | | | |
| | | | | 4 | | | |
| | | | | 5 | | | |
| | | | | 7 | | | |
| | | | | 8 | | | |
| | | | | 9 | | | |
| | | | | 10 | | | |
| | | | | 12 | | | |
| | | | | 14 | | | |
| | | | | 15 | | | |
| | | | | 16 | | | |
| | | |
Beneficial Ownership Prior to the
Date of this Prospectus |
| |
Beneficial Ownership
Assuming the Sale of All Shares registered pursuant to this Prospectus |
| ||||||||||||||||||
|
Name
|
| |
Number of
Shares(1) |
| |
Percent of
Outstanding Common Stock |
| |
Number of
Shares |
| |
Percent of
Outstanding Common Stock |
| ||||||||||||
|
Selling Stockholders
|
| | | | 45,533 | | | | | | * | | | | | | — | | | | | | * | | |
INFORMATION NOT REQUIRED IN PROSPECTUS
| |
Registration fee – Securities and Exchange Commission
|
| | | $ | 1,868.70 | | |
| |
Printing and engraving expenses
|
| | | | * | | |
| |
Legal fees and expenses
|
| | | | * | | |
| |
Accounting fees and expenses
|
| | | | * | | |
| |
Transfer agent fees and expenses
|
| | | | * | | |
| |
Miscellaneous
|
| | | | * | | |
| |
Total
|
| | | | * | | |
| | | | | | |
Incorporated by reference herein
|
| |
Filed
Herewith |
| |||||||||
|
Exhibit No.
|
| |
Description
|
| |
Form
|
| |
File No.
|
| |
Exhibit
|
| |
Filing Date
|
| |||
|
3.1
|
| | | |
8-K
|
| |
001-37478
|
| |
3.1
|
| |
07/09/2015
|
| | | | |
|
3.2
|
| | | |
10-Q
|
| |
001-37478
|
| |
3.1
|
| |
11/05/2021
|
| | | | |
|
4.1
|
| | | |
S-1/A
|
| |
333-204622
|
| |
4.1
|
| |
06/22/2015
|
| | | | |
|
5.1
|
| | | | | | | | | | | | | | | |
X
|
| |
|
23.1
|
| | | | | | | | | | | | | | | |
X
|
| |
|
23.2
|
| | | | | | | | | | | | | | | |
X
|
| |
|
24.1
|
| | | | | | | | | | | | | | | |
X
|
| |
|
107
|
| | | | | | | | | | | | | | | |
X
|
| |
Chief Financial Officer
| |
Signature
|
| |
Title
|
| |
Date
|
|
| |
/s/ Solomon Moshkevich
Solomon Moshkevich
|
| |
Chief Executive Officer, President and Director
(Principal Executive Officer) |
| |
November 10, 2026
|
|
| |
/s/ Michael Brophy
Michael Brophy
|
| |
Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)
|
| |
November 10, 2026
|
|
| |
/s/ Matthew Rabinowitz
Matthew Rabinowitz
|
| |
Executive Chairman of the Board of Directors
|
| |
November 10, 2026
|
|
| |
/s/ Roy Baynes
Roy Baynes
|
| |
Director
|
| |
November 10, 2026
|
|
| |
/s/ Roelof F. Botha
Roelof F. Botha
|
| |
Director
|
| |
November 10, 2026
|
|
| |
/s/ Rowan E. Chapman
Rowan E. Chapman
|
| |
Director
|
| |
November 10, 2026
|
|
| |
/s/ Thomas Lynch
Thomas Lynch
|
| |
Director
|
| |
November 10, 2026
|
|
| |
Signature
|
| |
Title
|
| |
Date
|
|
| |
/s/ Gail Marcus
Gail Marcus
|
| |
Director
|
| |
November 10, 2026
|
|
| |
/s/ Herm Rosenman
Herm Rosenman
|
| |
Director
|
| |
November 10, 2026
|
|
| |
/s/ Eric H. Rubin
Eric H. Rubin
|
| |
Director
|
| |
November 10, 2026
|
|
| |
/s/ Jonathan Sheena
Jonathan Sheena
|
| |
Director
|
| |
November 10, 2026
|
|
Exhibit 5.1
| November 10, 2026 | Client: 66867-00036 |
Natera, Inc.
13011 McCallen Pass
Building A, Suite 100
Austin, TX 78753
| Re: | Natera, Inc. Registration Statement on Form S-3 |
Ladies and Gentlemen:
We have acted as special counsel to Natera, Inc., a Delaware corporation (the “Company”), in connection with the preparation and filing with the Securities and Exchange Commission (the “Commission”) of a Registration Statement on Form S-3 (the “Registration Statement”) pursuant to the Securities Act of 1933, as amended (the “Securities Act”), relating to the resale from time to time by the selling stockholders described therein (the “Selling Stockholders”) of up to an aggregate of 68,023 shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), which consist of (i) 45,533 shares (the “Closing Shares”) of the Common Stock issued to the Selling Stockholders on or about November 10, 2026, in connection with the closing of the transactions contemplated by the Agreement and Plan of Merger, dated as of November 2, 2026, by and among the Company, two wholly owned merger subsidiaries of the Company, a privately held company and a stockholder representative (the “Merger Agreement”), and (ii) an estimated 22,490 additional shares of the Common Stock that may become issuable to the Selling Stockholders after the closing of the transactions pursuant to the Merger Agreement (the “Potentially Issuable Shares”).
In arriving at the opinion expressed below, we have examined originals, or copies certified or otherwise identified to our satisfaction as being true and complete copies of the originals, of such documents, corporate records, certificates of officers of the Company and of public officials and other instruments as we have deemed necessary or advisable to enable us to render this opinion. In our examination, we have assumed the genuineness of all signatures, the legal capacity and competency of all natural persons, the authenticity of all documents submitted to us as originals and the conformity to original documents of all documents submitted to us as copies. As to any facts material to this opinion, we have relied, to the extent we deemed appropriate and without independent investigation, upon certificates and statements of officers and other representatives of the Company.
Based upon the foregoing, and subject to the assumptions, exceptions, qualifications and limitations set forth herein, we are of the opinion that (i) the Closing Shares have been duly authorized and are validly issued, fully paid and non-assessable, and (ii) the Potentially Issuable Shares, when issued pursuant to the terms of the Merger Agreement, will have been duly authorized and validly issued and will be fully paid and non-assessable.
We consent to the filing of this opinion as an exhibit to the Registration Statement, and we further consent to the use of our name under the caption “Legal Matters” in the Registration Statement and the prospectus that forms a part thereof. In giving these consents, we do not thereby admit that we are within the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations of the Commission promulgated thereunder.
Very truly yours,
/s/ Gibson, Dunn & Crutcher LLP
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” in this Registration Statement (Form S-3) and related Prospectus of Natera, Inc. for the registration of common stock and to the incorporation by reference therein of our reports dated February 26, 2026, with respect to the consolidated financial statements of Natera, Inc., and the effectiveness of internal control over financial reporting of Natera, Inc., included in its Annual Report (Form 10-K) for the year ended December 31, 2025, filed with the Securities and Exchange Commission.
/s/ Ernst & Young LLP
San Jose, California
November 10, 2026